NCT03116217 (Antenatal) is a clinical trial in Posterior Urethral Valves, sponsored by University Hospital, Toulouse.

Who is sponsoring NCT03116217?

NCT03116217 is sponsored by University Hospital, Toulouse.

What condition does NCT03116217 study?

NCT03116217 studies Posterior Urethral Valves.

Is NCT03116217 still recruiting?

NCT03116217 is currently status unknown. Last updated 23 August 2023.

Last reviewed 2023-08-23 · How we verify

NCT03116217: Antenatal

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves

Status unknown Last updated 23 August 2023

What this trial tests

trial in Posterior Urethral Valves in 400 participants. Status unknown.

Timeline

26 June 2017

Primary endpoint
26 December 2023

26 December 2023

Quick facts

Lead sponsor	University Hospital, Toulouse
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	400
Start date	26 June 2017
Primary completion	26 December 2023
Estimated completion	26 December 2023
Sites	29 locations across France, Italy, Netherlands, Belgium, United Kingdom, Germany, Poland, Switzerland

Conditions studied

Posterior Urethral Valves — all drugs for Posterior Urethral Valves →

Sponsor

University Hospital, Toulouse

Who can join

Adults 18 to 65, female only, with Posterior Urethral Valves. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Validate the use of fetal urine peptidome-analysis and explore amniotic fluid markers for the stratification of fetuses with Posterior Urethral Valve for post-natal renal function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The ANTENATAL multicentre study to predict postnatal renal outcome in fetuses with posterior urethral valves: objectives and design.
Buffin-Meyer B, Klein J, van der Zanden LFM, Levtchenko E, et al · · 2020 · cited 19× · PMID 32699617 · DOI 10.1093/ckj/sfz107

Verify or expand the search:

Other University Hospital, Toulouse trials

Trials by the same sponsor.

NCT07497750 — Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver D · NA · not yet recruiting
NCT07507240 — The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Tre · NA · not yet recruiting
NCT07524088 — Contamination of Young Children Hair During Acute Cannabis Intoxication · NA · not yet recruiting
NCT07470580 — Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension · NA · not yet recruiting
NCT07423988 — Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the W · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03116217 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Toulouse
Last refreshed: 23 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03116217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing